Overview

Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects

Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the effects of the direct renin inhibitor, aliskiren, on flow-mediated dilation of the brachial artery and on central aortic pressure in diabetic patients with pre-hypertension or Stage 1 hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
Novartis